New and unusual scaffolds in medicinal chemistry

被引:352
作者
Marson, Charles M. [1 ]
机构
[1] UCL, Dept Chem, Christopher Ingold Labs, London WC1H 0AJ, England
关键词
BIOLOGICAL EVALUATION; IN-VIVO; RECEPTOR ANTAGONISTS; BINDING-AFFINITY; DRUG DISCOVERY; HIGHLY POTENT; INHIBITORS; DESIGN; DERIVATIVES; SERIES;
D O I
10.1039/c1cs15119c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Contemporary medicinal chemistry faces diverse challenges from several directions, including the need for both potency and specificity of any therapeutic agent; the increasingly demanding requirements of low toxicity shown across all patients treated; and the need for novelty in intellectual property, given the extensive use of benzenoid and heteroaromatic ring systems in numerous patents. Increasingly, such challenges are being met by a shift to new and/or unusual ring systems (scaffolds) that lie outside the field of (hetero)aromatic systems. This critical review surveys a necessarily limited selection of currently atypical scaffolds, chiefly drawn from the literature of the last three years, that have found application in medicinal chemistry, some being present in agents with therapeutic potential while others are found in agents already in clinical use (163 references).
引用
收藏
页码:5514 / 5533
页数:20
相关论文
共 162 条
[31]   Orally Bioavailable Antagonists of Inhibitor of Apoptosis Proteins Based on an Azabicyclooctane Scaffold [J].
Cohen, Frederick ;
Alicke, Bruno ;
Elliott, Linda O. ;
Flygare, John A. ;
Goncharov, Tatiana ;
Keteltas, Stephen F. ;
Franklin, Matthew C. ;
Frankovitz, Stacy ;
Stephan, Jean-Philippe ;
Tsui, Vickie ;
Vucic, Domagoj ;
Wong, Harvey ;
Fairbrother, Wayne J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1723-1730
[32]   Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists [J].
Coleman, Paul J. ;
Schreier, John D. ;
McGaughey, Georgia B. ;
Bogusky, Michael J. ;
Cox, Christopher D. ;
Hartman, George D. ;
Ball, Richard G. ;
Harrell, C. Meacham ;
Reiss, Duane R. ;
Prueksaritanont, Thomayant ;
Winrow, Christopher J. ;
Renger, John J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) :2311-2315
[33]  
COSTANZO MJ, 2009, Patent No. 2009067202
[34]   Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists [J].
Crombie, Aimee L. ;
Antrilli, Thomas M. ;
Campbell, Brandon A. ;
Crandall, David L. ;
Failli, Amedeo A. ;
He, Yanan ;
Kern, Jeffrey C. ;
Moore, William J. ;
Nogle, Lisa M. ;
Trybulski, Eugene J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) :3742-3745
[35]   Galactosyl Prodrug of Ketorolac: Synthesis, Stability, and Pharmacological and Pharmacokinetic Evaluations [J].
Curcio, Annalisa ;
Sasso, Oscar ;
Melisi, Daniela ;
Nieddu, Maria ;
La Rana, Giovanna ;
Russo, Roberto ;
Gavini, Elisabetta ;
Boatto, Gianpiero ;
Abignente, Enrico ;
Calignano, Antonio ;
Rimoli, Maria Grazia .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) :3794-3800
[36]  
DARGAZANLI G, 2008, Patent No. 20082906251
[37]  
DAVENPORT AJ, 2009, Patent No. 2009135842
[38]  
DEGRADO WF, 2010, Patent No. 2010033339
[39]   Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability [J].
Dillon, Gerald P. ;
Gaynor, Joanne M. ;
Khan, Denise ;
Carolan, Ciaran G. ;
Ryder, Sheila A. ;
Marquez, Juan F. ;
Reidy, Sean ;
Gilmer, John F. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (03) :1045-1053
[40]   The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277) [J].
Dong, Yuxiang ;
Wittlin, Sergio ;
Sriraghavan, Kamaraj ;
Chollet, Jacques ;
Charman, Susan A. ;
Charman, William N. ;
Scheurer, Christian ;
Urwyler, Heinrich ;
Tomas, Josefina Santo ;
Snyder, Christopher ;
Creek, Darren J. ;
Morizzi, Julia ;
Koltun, Maria ;
Matile, Hugues ;
Wang, Xiaofang ;
Padmanilayam, Maniyan ;
Tang, Yuanqing ;
Dorn, Arnulf ;
Brun, Reto ;
Vennerstrom, Jonathan L. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :481-491